ArticleMethods in molecular biology (Clifton, N.J.)2021

Case Study 6: Deconvoluting Hyperbilirubinemia-Differentiating Between Hepatotoxicity and Reversible Inhibition of UGT1A1, MRP2, or OATP1B1 in Drug Development.

Ian Templeton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.